These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37995936)

  • 1. Involvement of CXC chemokines (CXCL1-CXCL17) in gastric cancer: Prognosis and therapeutic molecules.
    Ullah A; Zhao J; Li J; Singla RK; Shen B
    Life Sci; 2024 Jan; 336():122277. PubMed ID: 37995936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXC chemokines and chemokine receptors in gastric cancer: from basic findings towards therapeutic targeting.
    Lee HJ; Song IC; Yun HJ; Jo DY; Kim S
    World J Gastroenterol; 2014 Feb; 20(7):1681-93. PubMed ID: 24587647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Chemokines in the Development of Gastric Cancer - Diagnostic and Therapeutic Implications.
    Pawluczuk E; Łukaszewicz-Zając M; Mroczko B
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role and clinicopathologic significance of CXC chemokine ligand 16 and chemokine (C-X-C motif) receptor 6 expression in gastric carcinomas.
    Xing YN; Xu XY; Nie XC; Yang X; Yu M; Xu HM; Liu YP; Takano Y; Zheng HC
    Hum Pathol; 2012 Dec; 43(12):2299-307. PubMed ID: 22863086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of CXC chemokines and their receptors in the progression and treatment of tumors.
    Zhu Q; Han X; Peng J; Qin H; Wang Y
    J Mol Histol; 2012 Dec; 43(6):699-713. PubMed ID: 22752457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of CXCL17 and GPR35 in Gastric Cancer Initiation and Progression.
    Li Y; Liu A; Liu S; Yan L; Yuan Y; Xu Q
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer.
    Cabrero-de Las Heras S; Martínez-Balibrea E
    World J Gastroenterol; 2018 Nov; 24(42):4738-4749. PubMed ID: 30479461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleiotropic effects of CXC chemokines in gastric carcinoma: differences in CXCL8 and CXCL1 expression between diffuse and intestinal types of gastric carcinoma.
    Eck M; Schmausser B; Scheller K; Brändlein S; Müller-Hermelink HK
    Clin Exp Immunol; 2003 Dec; 134(3):508-15. PubMed ID: 14632759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate tumor CXC-chemokine profile correlates with cell adhesion to endothelium and extracellular matrix.
    Engl T; Relja B; Blumenberg C; Müller I; Ringel EM; Beecken WD; Jonas D; Blaheta RA
    Life Sci; 2006 Mar; 78(16):1784-93. PubMed ID: 16263140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Clinicopathological Significance of the CXCR2 Ligands, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, and CXCL8 in Gastric Cancer.
    Yamamoto Y; Kuroda K; Sera T; Sugimoto A; Kushiyama S; Nishimura S; Togano S; Okuno T; Yoshii M; Tamura T; Toyokawa T; Tanaka H; Muguruma K; Ohira M; Yashiro M
    Anticancer Res; 2019 Dec; 39(12):6645-6652. PubMed ID: 31810929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of CXC chemokines and their receptors in cancer.
    Vandercappellen J; Van Damme J; Struyf S
    Cancer Lett; 2008 Aug; 267(2):226-44. PubMed ID: 18579287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL17-derived CD11b
    Hsu YL; Yen MC; Chang WA; Tsai PH; Pan YC; Liao SH; Kuo PL
    Breast Cancer Res; 2019 Feb; 21(1):23. PubMed ID: 30755260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors-A Review of Literature.
    Korbecki J; Kojder K; Kapczuk P; Kupnicka P; Gawrońska-Szklarz B; Gutowska I; Chlubek D; Baranowska-Bosiacka I
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXC chemokine receptor-2 ligands are necessary components of neutrophil-mediated host defense in invasive pulmonary aspergillosis.
    Mehrad B; Strieter RM; Moore TA; Tsai WC; Lira SA; Standiford TJ
    J Immunol; 1999 Dec; 163(11):6086-94. PubMed ID: 10570298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploration of prognostic biomarkers and therapeutic targets in the microenvironment of bladder cancer based on CXC chemokines.
    Sun X; Chen Q; Zhang L; Chen J; Zhang X
    Math Biosci Eng; 2021 Jul; 18(5):6262-6287. PubMed ID: 34517533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of CXC Chemokines in Cancer Progression.
    Wu T; Yang W; Sun A; Wei Z; Lin Q
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of proinflammatory cytokines and CXC chemokines (CXCL1-CXCL16) in the progression of prostate cancer: insights on their therapeutic management.
    Ullah A; Jiao W; Shen B
    Cell Mol Biol Lett; 2024 May; 29(1):73. PubMed ID: 38745115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression and role of CXC chemokines in colorectal cancer.
    Verbeke H; Struyf S; Laureys G; Van Damme J
    Cytokine Growth Factor Rev; 2011; 22(5-6):345-58. PubMed ID: 22000992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell surface heparan sulfate participates in CXCL1-induced signaling.
    Wang D; Sai J; Richmond A
    Biochemistry; 2003 Feb; 42(4):1071-7. PubMed ID: 12549928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets.
    Bizzarri C; Beccari AR; Bertini R; Cavicchia MR; Giorgini S; Allegretti M
    Pharmacol Ther; 2006 Oct; 112(1):139-49. PubMed ID: 16720046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.